Free Trial

REGENXBIO (RGNX) SEC Filings & 10K Form

REGENXBIO logo
$9.63 -1.51 (-13.55%)
(As of 11/15/2024 ET)

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
11/06/2024
3:10 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:49 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
10:42 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
09/18/2024
4:03 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
4:04 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:00 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:20 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:58 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:38 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:41 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:34 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:20 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
4:01 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:01 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:13 PM
REGENXBIO (Subject)
Simpson Curran (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
4:00 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
6:55 AM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
6:56 AM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
7:46 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:43 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:43 PM
REGENXBIO (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:39 PM
REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:40 PM
REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:41 PM
Fox Allan M. (Reporting)
REGENXBIO (Issuer)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:35 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:06 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:22 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:16 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:11 PM
REGENXBIO (Filer)
Form DEF 14A
04/04/2024
3:15 PM
REGENXBIO (Filer)
Form DEFA14A
04/04/2024
3:20 PM
REGENXBIO (Filer)
Form ARS
03/21/2024
4:20 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:09 AM
REGENXBIO (Filer)
Form 424B5
There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t
03/07/2024
5:05 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:03 AM
REGENXBIO (Subject)
Form FWP
03/06/2024
3:23 PM
REGENXBIO (Filer)
Form 424B5
03/05/2024
3:26 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:28 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2024
2:04 PM
GIC Private Ltd (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:10 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:11 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
6:16 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/18/2024
5:39 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:22 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:22 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:23 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:17 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
12:38 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:29 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
4:15 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGNX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners